10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2019 to Q4 2025

Type / Class
Equity / CLASS A COMMON STOCK
Symbol
TXG on Nasdaq
Shares outstanding
117,557,908
Price per share
$21.08
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
123,450,724
Total reported value
$2,012,493,808
% of total 13F portfolios
0%
Share change
+344,203
Value change
+$15,864,685
Number of holders
317
Price from insider filings
$21.08
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 12% $155,176,941 13,274,332 The Vanguard Group 30 Sep 2025
FMR LLC 11% +34% $207,074,635 +$55,657,224 12,696,254 +37% FMR LLC 31 Dec 2025
ARK Investment Management LLC 10% -12% $138,963,659 -$11,202,726 11,887,396 -7.5% ARK Investment Management LLC 30 Sep 2025
BlackRock, Inc. 7.6% $98,391,045 8,496,636 BlackRock, Inc. 30 Jun 2025
Sumitomo Mitsui Trust Group, Inc. 4.7% -14% $62,906,450 -$7,397,081 5,381,219 -11% Sumitomo Mitsui Trust Group, Inc. 30 Sep 2025
Amova Asset Management Americas, Inc. 4.7% -14% $62,855,762 -$7,397,081 5,376,883 -11% Amova Asset Management Americas, Inc. 30 Sep 2025
MILLENNIUM MANAGEMENT LLC 2.7% -48% $36,913,960 -$29,821,474 3,060,859 -45% Millennium Management LLC 30 Jun 2025

As of 31 Dec 2025, 317 institutional investors reported holding 123,450,724 shares of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG). This represents 105% of the company’s total 117,557,908 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) together control 82% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 11% 13,017,914 -1.9% 0% $212,322,177
ARK Investment Management LLC 11% 12,667,369 +6.6% 1.4% $206,604,788
FMR LLC 10% 11,917,482 +41% 0.01% $194,374,134
BlackRock, Inc. 8.5% 10,014,462 +5.9% 0% $163,335,875
Sumitomo Mitsui Trust Group, Inc. 4.7% 5,492,189 +2.1% 0.05% $89,577,603
Amova Asset Management Americas, Inc. 4.7% 5,486,153 +2% 1% $89,424,294
Quantinno Capital Management LP 4% 4,667,203 +34% 0.15% $76,122,081
MORGAN STANLEY 2.7% 3,196,893 +13% 0% $52,141,338
GOLDMAN SACHS GROUP INC 2.6% 3,087,267 +15% 0.01% $50,353,325
GEODE CAPITAL MANAGEMENT, LLC 2.4% 2,789,784 +2.9% 0% $45,509,358
JACOBS LEVY EQUITY MANAGEMENT, INC 2.2% 2,639,999 -10% 0.17% $43,058,384
AQR CAPITAL MANAGEMENT LLC 2.2% 2,579,051 -5.4% 0.02% $41,857,998
STATE STREET CORP 2.1% 2,512,519 -0.3% 0% $40,979,185
BANK OF AMERICA CORP /DE/ 1.6% 1,837,520 -46% 0% $29,969,951
RENAISSANCE TECHNOLOGIES LLC 1.3% 1,550,539 +48% 0.04% $25,289,291
DIMENSIONAL FUND ADVISORS LP 1.3% 1,517,581 +101% 0.01% $24,751,651
Capital World Investors 1.2% 1,452,300 0% 0% $23,687,013
WELLINGTON MANAGEMENT GROUP LLP 1.2% 1,448,765 -66% 0% $23,629,358
Casdin Capital, LLC 1.2% 1,400,000 1.4% $22,834,000
T. Rowe Price Investment Management, Inc. 1.1% 1,279,503 -4.7% 0.01% $20,869,000
TWO SIGMA ADVISERS, LP 1.1% 1,264,900 +5.4% 0.04% $20,630,519
MILLENNIUM MANAGEMENT LLC 1.1% 1,242,366 -77% 0.01% $20,262,989
VOLORIDGE INVESTMENT MANAGEMENT, LLC 1% 1,228,703 -7% 0.07% $20,040,146
TWO SIGMA INVESTMENTS, LP 0.98% 1,155,691 +95% 0.03% $18,849,320
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.94% 1,106,322 -3.4% 0% $18,044,112

Institutional Holders of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 123,450,724 $2,012,493,808 +$15,864,685 $16.31 317
2025 Q3 123,093,800 $1,438,929,466 +$5,463,797 $11.69 314
2025 Q2 122,631,794 $1,420,549,489 +$119,573,048 $11.58 293
2025 Q1 113,813,127 $993,375,835 +$50,874,984 $8.73 269
2024 Q4 104,507,907 $1,500,773,196 -$41,937,351 $14.36 270
2024 Q3 104,345,431 $2,355,358,198 -$6,296,831 $22.58 258
2024 Q2 105,353,108 $2,048,895,776 +$7,101,276 $19.45 254
2024 Q1 102,897,655 $3,861,610,085 +$222,058,012 $37.53 280
2023 Q4 95,956,168 $5,370,151,466 +$202,330,286 $55.96 267
2023 Q3 90,883,461 $3,748,861,587 +$66,054,684 $41.25 252
2023 Q2 89,127,845 $4,977,465,562 -$57,613,061 $55.84 269
2023 Q1 90,187,979 $5,027,414,812 +$211,396,981 $55.79 255
2022 Q4 87,545,856 $3,190,400,302 +$104,674,768 $36.44 253
2022 Q3 86,068,255 $2,449,753,227 -$43,840,073 $28.48 208
2022 Q2 86,085,516 $3,909,380,180 +$83,806,084 $45.25 228
2022 Q1 82,769,403 $6,293,794,627 -$74,133,769 $76.07 286
2021 Q4 79,764,587 $11,861,468,865 +$65,047,101 $148.96 347
2021 Q3 78,759,967 $11,461,957,413 +$127,530,777 $145.58 317
2021 Q2 77,884,791 $15,246,137,868 +$1,517,689,271 $195.82 332
2021 Q1 70,505,001 $12,760,866,584 +$832,242,795 $181.00 310
2020 Q4 66,229,914 $9,377,686,882 -$749,751,524 $141.60 299
2020 Q3 69,088,795 $8,545,655,879 +$1,071,434,021 $124.68 215
2020 Q2 61,004,107 $5,448,595,110 +$1,160,387,284 $89.31 141
2020 Q1 38,929,050 $2,426,163,019 +$612,574,707 $62.32 102
2019 Q4 30,795,732 $2,348,169,329 +$108,804,039 $76.25 85
2019 Q3 22,339,937 $1,125,942,955 +$1,125,942,955 $50.40 92